{{medical}}
{{drugbox
| Watchedfields = changed
| verifiedrevid = 216190718
| drug_name = 甲乙双酮
| IUPAC_name = (''RS'')-5-ethyl-3,5-dimethyl-oxazolidine-2,4-dione
| image = Paramethadione.svg
| imagename = 1：1混合（外消旋体）
| width = 250px
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 115-67-3
| ATC_prefix = N03
| ATC_suffix = AC01
| ATC_supplemental = 
| PubChem = 8280
| DrugBank = APRD00236
| IUPHAR_ligand = 7261
| DrugBank2_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank2 = DB00617
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 7979
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Z615FRW64N
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00495
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1100
| C = 7 | H = 11 | N = 1 | O = 3
| molecular_weight = 157.167 g/mol
| bioavailability = 
| protein_bound = 不显著
| metabolism = 
| elimination_half-life = 
| excretion = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = D
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status = 
| routes_of_administration = 
}}
'''甲乙双酮'''（Paramethadione）又称'''对甲双酮'''，是[[噁唑烷二酮|噁唑烷二酮]]类[[抗惊厥剂|抗惊厥剂]]。此药物已知会造成[[胎儿三甲双酮综合征|胎儿三甲双酮综合征]]。<ref> [http://www.nlm.nih.gov/cgi/jablonski/syndrome_cgi?term=paramethadione+syndrome&field=name Multiple Congenital Anomaly/Mental Retardation (MCA/MR) Syndromes] - Retrieved January 2007.</ref>

==参考文献==
{{reflist}}

==外部链接==
* {{DiseasesDB|33106}}
* {{cite journal | last = Hoffman | first = D | coauthors = Chun A | title = Paramethadione and metabolite serum levels in humans after a single oral paramethadione dose | url = https://archive.org/details/sim_journal-of-pharmaceutical-sciences_1975-10_64_10/page/1702 | journal = J Pharm Sci | volume = 64 | issue = 10 | pages = 1702–1703 | year = 1975 | pmid = 1185541 | doi = 10.1002/jps.2600641027}}

{{有機化合物小作品}}

[[Category:噁唑烷二酮|Category:噁唑烷二酮]]